Ashworth Alan 4
4 · CytomX Therapeutics, Inc. · Filed Oct 7, 2021
Insider Transaction Report
Form 4
Ashworth Alan
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-09-29+40,000→ 40,000 totalExercise: $4.93Exp: 2031-09-28→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]1/36th of the shares subject to the option vest on each monthly anniversary measured from September 29, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such vesting date.